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골관절염 연골세포의 세포사열과 그 조절기전
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목적 : 골관절염( o s t e o a r t h r i t i s )은 관절연골의 점차적인 소실과 이에 따른 활액막과 연골하골의 이차
적인 변화를 특징으로 하는 질환으로서 특히 노년층에서 높은 유병율을 보이는데 원인 및 병인에 대해서
는 아직 뚜렷하게 규명된 바가 없다. 한편, 세포사멸( a p o p t o s i s )은 세포괴사(cell necrosis)와는상대되
는 개념의 세포 사망으로서 염증반응이 없이 진행되는 것이 특징이고 자가면역질환, 종양, 퇴행성뇌질환
등의 기전연구에서 그 역할이 규명되고 있다. 최근몇몇 연구에 의하면, 골관절염의연골세포가 정상관절
의 연골세포에 비해 높은 비율의 세포사멸을 보이며, 또한F a s에 대한 항체를 처치한 경우에도 부분적으
로 세포사멸을 일으킨다고 하였다. 본연구는 골관절염의 연골세포에서 일어나는 세포사멸의 양상을 정상
관절의 연골세포와 비교하고, 세포사멸과관련한 수용체/리간드의발현을 조사하여 골관절염의 병인에 있
어서 세포사멸의 조절기전을 알아보았다.
방법 : 골관절염으로인공슬관절 치환술을 시행받은 환자의 관절연골과 외상에 의해 슬상절단술을 시행
받은 환자의 절단지에서 채취한 관절연골을 재료로, TUNEL assay를통해 세포사멸의 정도와 위치를
비교하였고 관절연골 조직에서 R N A 를 분리하여 역전사중합효소연쇄반응을통해 세포사멸의 조절에 참여
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I N T R O D U C T I O N
Osteoarthritis (OA) is one of the common-
est causes of disability in old age and has a
huge impact on hospital costs1 ). P th logical-
ly OA is characterized by degeneration of
articular cartilage, subchondral bone thick-
ening, marginal osteochondral outgrowth
(osteophyte), and eventual joint deformity.
The “d e g e n e r a t i o n” of articular cartilage is
the primary and main event in OA, and
consequently leads to the second change of
synovium and subchondral bone. This distin-
guishes OA from the other inflammatory
arthropathies in which cartilage degradation
occurs as a secondary response after synovial
i n f l a m m a t i o n2 ).
Regardless of the high prevalence, the eti-
ology and pathogenesis of OA are not well
understood. Some epidemiologic studies have
reported a strong association between aging
and OA 3 ). However, the changes observed in
articular cartilage from older individuals dif-
fer from those observed in articular cartilage
from OA patients, and moreover, normal
life-long joint use has not been shown to
cause degeneration4 ). Thus, OA is not caused
simply by aging and mechanical wear from
joint use5 ).
To investigate the pathogenesis of OA,
many studies have focused on the enzymatic
degrada ion of “m a t r i x” during cartilage
destruction in OA, as well as in numerous
cytokines and free on radicals which are
entw ned in the process of matrix degrada-
t i o n6 - 1 2 ). Articular “c h o n d r o c y t e s”, the only
cell type in articular cartilage, is the subject
to control turnover of matrix components
and has recently come to the attention of
res archers for its role in OA pathogenesis.
On  of the characteristics of articular carti-
lage in the early stage of OA is the appar-
ent attempt of tissue remodeling, such as an
increase in synthetic activity of proteogly-
cans by chondrocytes. As the disease
progress to the chronic phase, the cartilage
reveals a decrease in thickness and cellulari-
t y5 ). Based on this finding of
“h y p o c el l u l a r i t y” during the OA process, sev-
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하는 Fas 관련분자및 b c l - 2family, TRAIL 및그 수용체와 인터루킨-18 (IL-18)의mRNA 발현정도
를 조사하였으며 면역조직화학염색을 통하여 FasL 단백의발현을 알아보았다.
결과 : 형광d U T P 를 이용한 TUNEL assay에서골관절염이 없는 정상 대조군 관절연골 4례 모두에
서는 세포사멸을 보이는 세포를 찾아볼 수 없었으나 골관절염의 관절연골 7례의표본 중 6례에서전형적
인 세포사멸 세포들을 관찰할 수 있었다. 역전사중합효소연쇄반응에서는caspase-3, caspase-8, Fas 및
F a s L의 mRNA 발현정도가 골관절염의 연골에서 정상 대조군 연골에 비해 증가하였으며, 특히F a s L는
일부 골관절염에서 현저히 증가된 양상을 보였다. FasL의유도체로 알려진 I L - 1 8은 F a s L가 증가된 환
자에서 함께 강한 발현을 보였다. 면역조직화학염색에서는정상 대조군 연골에서보다 골관절염의 연골에
서 FasL 단백이현저히 강하게발현됨을 관찰하였다.
결론 : 본연구는 골관절염 환자의 관절연골에서 의미있게 증가한 세포사멸과 F a s L의 발현을 관찰하였
으며, 이는Fas/FasL 경로를통한 세포사멸이 골관절염에서 일어나는 관절연골의 퇴화에 기여할 것을
시사한다. 또한F a s L의 유도체 중 하나인 I L - 1 8의 발현도 관찰되었다. 이상의결과는 차후 골관절염 치
료에 있어서새로운 접근을제시하는 데 일조할것으로기대된다.
색인단어 : 연골세포, 세포사멸, 골관절염, Fas 리간드, 인터루킨- 1 8
eral studies have reported that apoptosis of
articular chondrocytes occurs and increases
in OA2 , 1 3 ). However, the underlying mecha-
nism or the molecules responsible for trig-
gering the apoptosis in OA chondrocytes is
still under investigation.
There are a variety of signals to initiate
apoptosis: elimination of growth factors,
ultraviolet or γ-irradiation, exposure to nox-
ious chemicals or chemotherapeutic drugs,
and activation of death receptors1 4 - 1 6 ). Several
pathways and related molecules leading to
apoptosis have been well characterized.
Death receptors and ligands play a central
role in instructive apoptosis1 7 ) : Fas (al o
called CD95 or Apo-1) and Fas ligand (FasL,
also called CD95L or APO-1L)1 8 ); DR4 (also
called TRAIL-R1)/DR5 (also called TRAL-
R2) and TRAIL (TNF related apoptosis-
inducing ligand, also called APO-2L)1 9 , 2 0 ).
TRAIL has decoy receptors (DcRs), which
interfere death signal, DcR1 (also called
TRAIL-R3) and DcR2 (also called TRAIL-
R 4 )2 1 - 2 3 ). Downstream signal activates adaptor
molecules, for example FADD, and caspase-8
(FLICE), initiate the caspase cascade, and
then evetually activate caspase-3, which
degrades death substrates and dossemble
cells. Cytochrome c in the mitochondria also
play an important role in apoptosis in associ-
ation with Apaf-1 and caspase-9 (Apaf-3).
This mitochondrial activity can be regulated
by members of the Bcl-2 family: anti-apop-
totic proteins such as Bcl-2 and Bcl-xL pro-
mote cell survival, while pro-apoptotic pro-
teins such as Bax, Bad, and Bcl-xS promote
a p o p t o s i s2 4 , 2 5 ).
The present study aimed to investigate the
apoptosis of articular chondrocytes in OA
cartilage, and which apoptotic pathway and
molecular mechanisms are involved in the
apoptosis of articular chondrocytes in OA.
Apopt tic chondrocytes in articular cartilage
were determined by TUNEL (TdT-mediated
dUTP-biotin nick end labeling) staining with
fluorescein-dUTP. Evaluation of the various
apoptosis-related genes expression-b c l - 2f a m-
ily genes, caspase members, Fas-related
genes, TRAIL and its receptors, and IL-18-
was done by RT-PCR. Immunohistochemical
staini g was included to examine the expres-
sion of FasL in OA cartilage at the protein
evel, in correlation with the expression level
of FasL transcripts.
MATERIALS AND METHODS
1) Sources of articular cartilage: O v e r a  l
10 specimens of OA cartilage obtained from
total knee replacement surgery (ages 52-78)
were included in this study. Control non-OA
cartilages were obtained from 5 donors with-
out known history of joint disease at the
time of above-knee amputation surgery
(ages 44-70). Cartilages were immediately
washed in ice-cold phosphate-buffered
salin , and cut into small pieces from the
femor l condyles and tibial plateaus. One
piece of cartilage was preserved in 4%
paraformaldehyde for TUNEL and immuno-
histochemical staining; the other pieces were
qu ckly minced into thin slices and trans-
ferred into a TRIzol reagent (Gibco BRL,
Grand Island, NY, USA) for RNA isolation.
2) TUNEL staining:To determine whether
apoptosis of chondrocytes occurs and increase
in OA cartilage, TUNEL staining was per-
formed in 11 cartilage, 7 OA cartilages and 4
non-OA control cartilages, using the in situ
cell death detection kit (MBL, Nagoya,
Japan). This kit is an apoptosis detection kit
bas  o   TUNEL (TdT-mediated dUTP-
biotin nick end labeling) method and uses flu-
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orescein-dUTP to label DNA strand breaks. In
cells in which apoptosis occurs, the chromatin
DNA is cut by endonuclease at linker DNA
site between nucleosomes. Then, DNA frag-
ments, which are a number of multimers of
nucleosomal units, exist in nuclei. In TUNEL
method, 3’-OH DNA ends generated by DNA
fragmentation is nick end labeled with fluo-
rescein-dUTP, mediated by terminal deoxynu-
cleotidyl transferase (TdT). Cartilages were
immediately fixed in 4% paraformaldehyde,
embedded in paraffin, and cut into 5-μm sec-
tions. The sections were treated with a mix-
ture of TdT and FITC-dUTP according to the
m a n u f a c t u r e r’s instructions. Counterstaining
was done with Propidium Iodide. After
mounting, the slides were examined under a
fluorescent microscopy.
3) RNA isolation from articular cartilage:
Cartilage was quickly minced into thin slices
with a scalpel, transferred into a TRIzol
reagent with 1ml per 100mg cartilage.
Approximately 1500 to 2000mg of cartilage
chips in TRIzol at one time was pulverized
in the Polytron (OmniMacro Homogenizer,
Waterbury, CT, USA) for 15 to 30 seconds
at the rate of medium impact frequency.
Then, the pulverized cartilage powder in
TRIzol was incubated for 30 min on a rock-
ing plate at room temperature. For protein
and tissue debris extraction, chloroform (400
μl/ml of TRIzol) was added to the mixture
and centrifuged. RNA in the aqueous phase
was further purified through a silica-gel-
based membrane spin column (RNeasy kit,
Qiagen Inc., Santa Clara, CA) according to
the manufacturer’s protocol. About 1-3μg
total RNA could be obtained from 100mg
c a r t i l a g e .
4) Multiplex RT-PCR for apoptosis-related
g e n e s :Total RNA 5 μg was used to carry
out a reverse transcription with the random
hexamer primer in a total 20μl. The result-
ing reverse transcriptase product was
xpanded using the CytoXpress Multiple
cDNA amplification kits for apoptosis panels
(Biosource, Camarillo, CA) and specific
primers for the sequences of interest. For
the multiple PCR (MPCR) of Caspase-3
(LICE), bcl-2, bax, bcl-xS, and bcl-xL, the
quantitative PCR detection kit (Biosource
cata og #QHM0021); for the MPCR of Fas,
FasL, TRAIL, and Caspase-8 (FLICE), the
quantitative PCR detection kit (Biosource
catalog #QHM0031) was used according to
he manufacturer’s instructions. To the 5 μl
of total RNA, the 5μl 10x hAPO2MPCR
primers, the 4μl 3.12mM dNTP, the 5μl 10×
hAPO2GMPCR buffer, and the 0.5μl (
u n i t s /μl) AmpliTaq DNA polymerase
(Pe k n-Elmer Cetus Corp.) were added.
After a  in tial denaturing step at 96°C for
1 min, the mixture was run the following
temperature profile for 2 cycles: denaturing
step at 96°C for 1 min, annealing step at
5 7°C for 4 min, and extension step at 72°C
for 1 min. Then it was continued the cycle
pr gram as follows for 33 cycles: denaturing
step at 94°C for 1 min, annealing step at
5 6°C f r 2.5 min, and extension step at 72°C
for 1 min. The PCR products were analyzed
by electrophoresis in 2% agarose that con-
tained ethidium bromide and photographed
with UV light excitation.
5) Semiquantitative RT-PCR for FasL, IL-18,
and TRAIL-receptors:For the quantitation of
FasL, IL-18, and TRAIL-receptors tran-
scripts, semiquantitative RT-PCR was per-
formed with the following primers. For the
internal control, β-actin primers were used.
F a  L 5’-ATG TTT CAG CTC TTC CAC
CTA CAG AAG GA-3 ’ a n d
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5’-CAG AGA GAG CTC AGA TAC
GTT GAC-3’ 2 6 );
I L - 1 85’-GCT TGA ATC TAA ATT ATC
AGT C-3 ’ a n d
5’-GAA GAT TCA AAT TGC ATC
TTA T-3 ’2 7 );
D R 4 5’-TTA CAC CAA TGC TTC CAA
CAA T-3 ’ a n d
5’-AGG AGT CAA AGG GCA CGA
TGT T-3 ’;
D R 5 5’-ATT GTG GCT GTG TTT GTT
T G C - 3 ’ a n d
5’-TGT TGG CTC TGC TGG CTC
C T G - 3 ’;
D c R 1 5’-GAT CCC CAA GAC CCT AAA
G T T - 3 ’ a n d
5’-GGT TTC CAC AGT GGC ATT
G G C - 3 ’;
D c R 2 5’-AGG GAT GGT CAA GGT CAG
TAA T-3 ’ a n d
5’-GAT GTC AGC GGA GTC AGC
GTC A-3’ ;
β- a c t i n5’-CGT GGG CCG CCC TAG GCA
C C A - 3 ’ a n d
5’-TTG GCC TTA GGG TTC AGG
GGG G-3 ’.
To the 3μl of total RNA, the 1μl ach
primers, the 4μl 1.25 mM dNTP, the 2.5μl
1 0×buffer, and the 0.25μl (5units/μl) Ampli-
Taq polymerase (Perkin-Elmer Cetus Corp.)
were added. The mixture was run the fol-
lowing temperature profile for 24 to 35
cycles: denaturing step at 94°C for 30 sec,
annealing step at 55°C to 56°C for 30 sec,
and extension step at 72°C for 1 min. The
PCR products were analyzed by electrophore-
sis in 1.5% agarose that contained ethidium
bromide and photographed with UV light
e x c i t a t i o n .
6) Immunohistochemical staining for FasL:
To confirm the expression of FasL at the
protein level, immunohistochemical staining
for FasL was performed with goat polyclonal
antibody for human FasL (N-20, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) in 11
cartilages. To amplify the signal on immuno-
histochemistry, two strategies were used, i.e.
antigen retrieval in citrate buffer, and signal
amplification with biotinylated tyramide2 8 ).
For the former, heat-induced epitope
retrieval was conducted by immersing the
slides in Coplin jars filled with 10 mM/L cit-
rate buffer (pH 6.0) and boiling the buffer
for 30 minutes in a pressure cooker (Nordic
Ware, Minneapolis, MN, USA) inside a
microwave oven at 700 W. For the latter,
the Renaissance TSA indirect kit (NEN Life
Science, Boston, MA, USA), which included
streptavidin-peroxidase and biotynylated
tyramide, was used. Cartilages were inter-
preted as positive for FasL by immunohisto-
chemistry when at least weak to moderate
cytoplasmic staining was seen in greater
than 30% of the chondrocytes. The
immunoreactivity for FasL was graded as 0
(0~10% of the cells with a very weak sig-
nal), 1+ (11~30% of the cells with a weak to
moderate signal), 2+ (31~60% of the cells
with a moderate to strong signal), or 3+ (＞
60% of the cells with a strong signal)2 9 ). Ne -
a ive control slides were treated by peptide
neutralization and replacement of primary
antibody with non-immune goat serum.
R E S U L T S
1) TUNEL staining in articular cartilage:
TUNEL-positive cells were seen in 6 among
7 cases of OA examined by TUNEL staining
(apoptotic index: 5~30%, mean: 11%)
(Table 1, Fig. 1). In contrast, no TUNEL-
positive cells were seen in all 4 cases of con-
trol non-OA.
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2) mRNA expression of various apoptosis-
related genes in OA cartilage:Expression of
bcl-2, bcl-xL, bax, bcl-xScaspase-3, cas-
pase-8, Fas, FasL, and TRAIL was detected
by using commercially available multiplex
RT-PCR kits. Caspase-3 and caspase-8 were
constitutively expressed in overall cartilages,
whereas their expression was slightly
increased in OA cartilages compared with
control non-OA cartilages (Fig. 2, Table 2).
The expression of bcl-2 family genes was
w ak in overall cartilages and no significant
difference between OA and control non-OA.
Meanwhile, Fas expression was overall
strong in both OA and control non-OA carti-
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Fig. 1.TUNEL staining in articular cartilage (×200). Negative red cells are seen in control non-OA
cartilage (A ), while positive green cells in OA cartilage. Note relatively low number of cells in
OA ( B) .
Table 1.Apoptotic index in articular cartilage through TUNEL staining
Control Non-OA Cartilage OA Cartilage
( N = 4 ) ( N = 7 )
Apoptotic indexa 0 % 1 1±8 . 8 %b
(range, 5-30%)
a. Apoptotic index was calculated as the percentage of morphologically identified apoptotic cells and
apoptotic bodies in the total number of cells shown on a section.
b. Mean±SD of 6 cases of OA cartilage showed apoptotic chondrocytes.
lages, with a slight increase in OA cartilage.
FasL expression was generally weak but
showed a tendency to increase in some OA
cartilages (Fig. 3). Another death-inducing
ligand, TRAIL, showed generally moderate
expression and no definite difference
between OA and control cartilage (Fig. 3).
3) mRNA expression of FasL and IL-18:
There w re no previous reports describing
about the expression of FasL in articular
cartilage, however FasL transcript was
detected in multiplex RT-PCR system (Fig.
3). For more precise quantitation of FasL
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Table 2.mRNA expression of apoptosis-related genes in articular cartilage
Control Non-OA CartilageOA Cartilage
( N = 3 ) ( N = 7 )
b c l - 2family genes
b c l - 2 + +
b c l - x L + + + +
b a x + +
b c l - x S ± ±
Caspase members
C a s p a s e - 3 * + + + + + + +
C a s p a s e - 8 * + + + + +
Fas-related genes
F a s * + + + +++ /++++
F a s L * + + ~ + + + + +
I L - 1 8 + ~ + + + + + + ~ + + + + +
TRAIL-related genes
T R A I L + + + +
D R - 4 ± ±
D R - 5 + +
D c R 1 + + + + + + + +
D c R 2 + + + + + +
The grading of mRNA expression of these genes was based on the values measured by densitometer and
converted by the relative % ratio to the expression level of house-keeping genes (GAPDH or β-actin) as
100%: ±, < 30% intensity of with very weak levels; 1+, 30-60% of intensity with weak levels; 2+, 60-
90% of intensity with moderate levels; 3+, 90-120% of intensity with moderate to strong levels; 4+, 120-
150% of intensity with strong levels; and 5+, > 150% intensity with very strong levels. *, different
expression levels between OA cartilage and control non-OA cartilage.
Fig. 2.Multiplex RT-PCR for bcl-2 family and caspase-3. Samples from 1 to 3 are control
cartilage and from 4 to 10 were OA cartilage.
expression, semiquantitative RT-PCR of
FasL was separately performed. FasL
expression was significantly different in OA
cartilage compared to control non-OA carti-
lage (Fig. 4, Table 2). No or weak FasL
expression was seen in non-OA cartilage,
while sh wing highly increased expression in
OA cartilage, even stronger than in the pos-
itiv  co rol, activated Jurkat cell. Particu-
larly strong expression was shown in several
OA cartilages (Fig.4, lanes 4-6, 8, 10).
Although the expression of IL-18, known as
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Fig. 4.Semiquantitative RT-PCR for FasL and IL-18. Sample from 1 to 3 were control
cartilage and from 4 to 10 were OA cartilage. In sample 4, part to the cartilage
grossly normal-looking (4N) and the typically degenerated cartilage (4O) were sep-
arately harvested. RNA was extracted from each cartilage and RT-PCR was done.
Fig. 3.Multiplex RT-PCR for Fas, FasL, TRAIL, and caspase-8 genes. Sample from 1 to
3 were control cartilage and from 4 to 10 were OA cartilage.
Fig. 5.Semiquantitative RT-PCR for TRAIL-receptors. Samples from 1 to 3 were control
cartilage and from 4 to 10 were OA cartilage.
one of the FasL-inducing factors, did not
show a clear correlation with the expression
of FasL, the cartilage that showed higher
expression of FasL also showed higher
expression of IL-18 (Fig. 4). Interestingly,
in the same patient, a part of grossly nor-
mal-looking cartilage (Fig. 4, lane 4N)
showed weak expression of IL-18, while the
other typically degenerated part of cartilage
(Fig. 4, lane 4O) showed strong expression
of IL-18.
4) mRNA expression of TRAIL-receptors:
Among TRAIL-receptors, DR-4 was overall
weakly expressed in both OA and control non-
OA cartilages. DR-5 was expressed with mod-
erate levels in some OA cartilage, but with
overall weak levels in other OA and non-OA
cartilages (Fig. 5 and Table 2). Whereas,
DcR1 and DcR2 were highly expressed in
overall OA and non-OA (Fig. 5, Table 2).
5) FasL immunohistochemistry: The expres-
sion of FasL was detected in all 7 samples of
OA cartilage inwhich we performed
immu ohistochemistry, with grade 1+ in 2
samples and grade 3+ in 5 samples, whereas
non-OA cartilage showed grade 0 immunore-
activity for FasL in 3 samples and grade 1+
in 1 sample (Fig. 6, Table 3). In positive
chondrocytes, detectable cell surface staining
was accompanied by strong granular cyto-
plasmic reactivity. There was no preference
f r distribution of FasL-positive chondrocytes
from the superficial layer to deep layer.
N gative controls, using competing epitope
peptide, for FasL showed no signal. The
grading of immunoreactivity for FasL in car-
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Fig. 6.Immunohistochemical staining for FasL in articular cartilage (×400). Negative cells with bluish
pale cytoplasm are seen in control non-OA cartilage (A ), while positive cells with brown granu-
lar cytoplasmic reactivity are seen in OA cartilage (B) .
tilage was well correlated with the level of
expression of FasL transcript (Table 4).
D I S C U S S I O N
Recent OA research has mainly followed
two lines: one line concentrates on repair of
localized cartilage injuries and the other line
examines possible causes of the disease with
biologic or molecular methods, in order to
find ways to stop its initiation or progression
or to reverse the condition1 ). Current treat-
ment mo ality of OA varies from conserva-
ive measures to surgical interventions, how-
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Table 3.FasL Immunoreactivity in articular cartilage
Control Non-OA CartilageOA Cartilage
( N = 4 ) ( N = 7 )
Positive cartilagesa
n/N (%) 0 % 8 6 %
I m m u n o r e a c t i v i t y
0 3 cartilages -
1 + 1 cartilage 2 cartilages
2 + - -
3 + - 5 cartilages
a. Quantitation of FasL positivity: 0, 0~10% of the cells with a very weak signal; 1+, 11~30% of the
cells with a weak to a moderate signal; 2+, 31~60 % of the cells with a moderate to strong signal; 3+,
>60% of the cells with a strong signal.
Table 4.Correlation between mRNA and protein expression of FasL
Case No.
F a s L I L - 1 8
Transcript levela Protein levelb Transcript levela
C o n t r o l 1 + N I + +
N o n - O A 2 ± 0 +
c a r t i l a g e 3 ± + + + + + +
( N = 5 ) 1 4 N I 0 N I
1 5 N I 0 N I
4 N + + N I +
4 O + + + + + + + + + +
5 + + + + + + + + + + +
O A 6 + + + + + + + + + + + + +
c a r t i l a g e 7 + + + + + + + +
( N = 1 0 ) 8 + + + N I + + + +
9 ± N I +
1 0 + + + + + N I + + + + +
1 1 N I + + + N I
1 2 N I + N I
1 3 N I + + + N I
NI: Not informed
a. The criteria of grading is same as the one in Table 2.
b. The criteria of grading is same as the one in Table 3.
ever these are not relied on a certain under-
standing of the etiology or pathogenesis of
OA. Based on this idea, the present study
has been designed to investigate the apopto-
sis of articular chondrocytes in OA cartilage,
especially which apoptotic molecules are
involved in the apoptosis of articular chon-
drocytes in OA to propose the underlying
mechanism regulating apoptosis of chondro-
cytes in OA pathogenesis.
The primary and central event of OA is
progressive degradation of articular carti-
lage. The etiology and pathogenesis of this
commonest disease is not yet well under-
stood. Recent reports have showed evidences
that the apoptosis of articular chondrocytes
occurred and increased in OA8 , 1 3 )and apopto-
sis of articular chondrocytes might be relat-
ed to decreased collagen type II in the
m a t r i x3 0 ). These studies have suggested that
apoptosis plays an important role in the OA
pathogenesis and is linked with cartilage
destruction seen in OA. The present study
also documented compatible results with the
previous reports, that 6 of 7 cases of OA
cartilage revealed fluorescein-dUTP tagged
positive chondrocytes through TUNEL stain-
ing (apoptotic index: 5~30%) but all 4 cases
of control non-OA cartilage showed no posi-
tive chondrocytes. The apoptotic index was
lower in this study through TUNEL staining
than in previous report through flowcytome-
try because the enzymatic digestion process
might accelerate apoptosis in chondrocytes1 3 ).
New technique measuring active form cas-
pase-3 by immunohistochemical method can
be tried to detect apoptosis of chondrocytes
with more specificity.
Meanwhile, investigations about the mole-
cular mechanisms and underlying pathway,
regulating apoptosis in OA chondrocyte, are
quite limited in quantity. A study have
r ported that b c l - 2in articular chondrocytes
w s down-regulated by serum withdrawal or
retinoic acid treatment, while the level of
bax expressi n remained unchanged com-
pared with control cells, suggesting a
inhibitory role of b c l - 2in chondrocytes apop-
t o s  s3 1 ). In the present study, among b c l -2
family genes, both anti-apoptotic and pro-
ap ptotic members showed overall similar
level of expression, without significant dif-
ference between OA and control non-OA
cartilage. It suggests that they do not play a
crucial role in OA pathogenesis.
Caspase-8 is a kind of initiator caspase
associated with apoptosis involving death
eceptor and ca pase-3 is an effecter caspase
to degrade death substrates and eventually
d sassemble cells. There was a report that
caspase-3 expression was detected in carti-
lage chondrocytes through immunostaining3 2 ).
Cons s ently, the present study has also
demons rated caspase-3 and caspase-8 highly
xpres ed in articular cartilage, and with
light ncrease in OA cartilage than in con-
trol non-OA cartilage. Caspase regulation is
currently targeted as potential treatment
strategy in neurodegenerative diseases,
ischemia-reperfusion injury, graft-versus-
host disease, and autoimmune disorders by
manipulation of apoptosis with caspase
inhibitor of small-peptide3 3 ). OA also can be
a candidate disease for application of this
type of therapy.
TRAIL, ne of death receptor ligand medi-
ating apoptosis, is recently documented1 9 , 3 4 ).
TRAIL expression in articular cartilage has
not yet shown in literature. In the present
study, TRAIL transcript demonstrated simi-
lar level of expression in overall OA and con-
trol non-OA cartilage. Its death-mediating
receptors, DR-4 and DR-5, were expressed
wi h weak l vels on overall OA and control
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non-OA cartilage, whereas its death-inhibit-
ing decoy receptors, DcR1 and DcR-2, were
expressed with high levels on overall OA and
control non-OA cartilage. This result sug-
gests that the TRAIL/TRAIL-receptor path-
way does not play a significant role in apop-
tosis of chondrocytes in OA cartilage.
As for Fas/FasL expression in articular
chondrocytes, there are a report that a sub-
population of chondrocytes expressed Fas and
was susceptible to Fas-induced apoptosis, but
FasL transcript was not detectable in resting
or activated normal or OA chondrocytes7 ).
However, recently the expression of FasL
transcripts has been reported in articular
chondrocytes from a cell culture system3 5 ). In
the present study, Fas transcript expressed
overall at high levels in cartilages of OA and
non-OA, and showed slight increased expres-
sion in OA cartilage than in control non-OA
cartilage. The expression of FasL transcripts
and protein was both documented in articu-
lar cartilages, at strongly high level on OA
cartilage. Unlike expression of Fas, which is
constitutive in many tissues throughout
human body1 9 , 3 4 ), the expression of FasL is
restricted mainly to in activated T-cells and
natural killer (NK) cells, and to immune-
privilege sites such as testis, eye chamber,
and parts of the nervous system1 8 ). The docu-
mentation of FasL expression in articular
cartilage is for the first time, in our knowl-
edge. The verification of FasL from cartilage
tissue reflects the in vivo status more closely
than from culture system. For the primary
cell culture, chondrocytes are mandatory to
pass through enzymatic digestion process, a
kind of selection step for survival. Besides,
the enzymatic digestion process itself can
induce apoptosis.
There are several molecules known as
inducer of FasL, including oxidative stresses,
parts of v ral proteins, and IL-183 6 ). IL-18,
originally identified as interferon-?-inducing-
factor, is a ew member of the IL-1 family
of cytokines3 7 )and is also known as one of
inducer of FasL in T-cells and NK cells3 8 , 3 9 ).
A ticular ch ndrocytes produce the IL-18 pre-
cursor and, in response to IL-1 stimulation,
secrete the mature form of Il-18 as well as
con ribute to cartilage degradation2 7 ). In the
ent study, although the expression of IL-
18 tran cript did not show the clear correla-
tion with the expression of FasL, the carti-
lage expressing the higher level of FasL also
expressed the higher level of IL-18. It sug-
gests IL-18 m y induce FasL in chondrocytes
of OA cartilage.
On the ba is of these results, normal
chondrocytes do not undergo apoptosis
because they express quite amount of Fas
but egligible amount of FasL. However,
increased expression of FasL, which may be
induced by IL-18 activation, in OA cartilage
can ad to a simultaneous expression of Fas
and FasL, lead  to “kiss of death”, and
result in apoptotic cell death. FasL expres-
sion may be a critical limiting factor for the
acceleration of chondrocytes death during
the cours  of OA pathogenesis, because Fas
 constitutively expressed in normal chon-
drocytes. To tell this story, many further
studies are necessary. One of them is to
determine whether IL-18 treatment induces
the expression of FasL and cell death in
chondrocytes culture system. While, the bcl-
2 family and TRAL/TRAIL-receptor path-
way seem not to play a significant role in
ap ptosis seen in OA cartilage.
In summary, this study implies Fas/FasL
pathway may play an important role in
apoptosis of chondrocytes during OA patho-
ge esis, so that OA can be targeted by ther-
apeutic prevention of apoptosis to stop the
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initiation or progression or to reverse the
c o n d i t i o n .
C O N C L U S I O N S
The present study has elucidated that
apoptosis occurred and was increased in OA
cartilage and documented that FasL was
expressed in articular cartilage, at high lev-
els in OA cartilage, and was probably trig-
gered by IL-18. In conclusion, the Fas/FasL
pathway may play an important role in the
apoptosis of chondrocytes in OA pathogene-
sis. Therefore, the Fas/FasL mediated apop-
totic pathway in OA can be targeted by
therapeutic prevention of apoptosis to modi-
fy the disease process.
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